Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;30(2):141-9.
doi: 10.1002/mds.26068. Epub 2014 Dec 5.

Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease

Affiliations
Review

Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease

T Celeste Napier et al. Mov Disord. 2015 Feb.

Abstract

Patients with Parkinson's disease (PD) may experience impulse control disorders (ICDs) when on dopamine agonist therapy for their motor symptoms. In the last few years, a rapid growth of interest for the recognition of these aberrant behaviors and their neurobiological correlates has occurred. Recent advances in neuroimaging are helping to identify the neuroanatomical networks responsible for these ICDs, and together with psychopharmacological assessments are providing new insights into the brain status of impulsive behavior. The genetic associations that may be unique to ICDs in PD are also being identified. Complementing human studies, electrophysiological and biochemical studies in animal models are providing insights into neuropathological mechanisms associated with these disorders. New animal models of ICDs in PD patients are being implemented that should provide critical means to identify efficacious therapies for PD-related motor deficits while avoiding ICD side effects. Here, we provide an overview of these recent advances, with a particular emphasis on the neurobiological correlates reported in animal models and patients along with their genetic underpinnings.

Keywords: 6-OHDA; PET; basal ganglia; dopamine agonists; fMRI; imaging; l-dopa; pramipexole; prefrontal cortex.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosures:

T. Celeste Napier, Ph.D. Dr. Napier has no financial conflict of interest with respect to the content of this manuscript. Dr. Napier has received research support from the National Institutes of Health, the Michael J. Fox Foundation and the National Center for Responsible Gaming. Dr. Napier has received compensation for the following: consulting for a not-for-profit health education center and for law offices on issues related to addictions and impulse control disorders; speaking on addictions at community town hall meetings, public high schools, community-based not-for-profits, and professional meetings of drug courts; providing grant reviews for the National Institutes of Health and other agencies; and academic lectures and grand rounds. Dr. Napier is a member of the Illinois Alliance on Problem Gambling, and she provides expert advice to Cures Within Research Foundation, LLC.

Jean-Christophe Corvol M.D., Ph.D. has no financial conflict of interest with respect to the content of this manuscript. Dr. Corvol has received research support from the French Ministry of Health, INSERM, the French Parkinson’s disease association, and the Michael J. Fox Foundation. Dr. Corvol has received honoraria for his participation to clinical trials and travel grants for scientific meetings from Novartis, UCB, Biogen, Sanofi-Aventis.

Anthony A. Grace, Ph.D. Dr. Grace has no financial conflict of interest with respect to the content of this manuscript. Dr. Grace has received research support from the National Institutes of Health, Lundbeck, and Lilly. Dr. Grace has received compensation for consulting/honoraria from Johnson & Johnson, Lundbeck, Pfizer, GSK, Puretech Ventures, Merck, Takeda, Dainippon Sumitomo, Otsuka, Lilly, Roche, Asubio, Abbott

Jamie D. Roitman PhD. Dr. Roitman has no financial conflict of interest with respect to the content of this manuscript. Dr. Roitman has received research support from the National Institutes of Health and the Brain Research Foundation.

James B. Rowe B.M., Ph.D., FRCP. Dr. Rowe has no financial conflict of interest with respect to this manuscript. Dr Rowe has received research support from the Wellcome Trust, the Medical Research Council, the National Institute for Health Research, the James S McDonnell Foundation, the Newton Trust and Evelyn Trust.

Valerie Voon M.D., Ph.D., FRCPC. Dr. Voon has no financial conflict of interest with respect to the content of this manuscript. Dr. Voon has received support from the Wellcome Trust.

Antonio P. Strafella M.D., Ph.D., FRCPC. Dr. Strafella has no financial conflict of interest with respect to the content of this manuscript. Dr. Strafella has received research support from Canadian Institute of Health Research, Parkinson Society Canada, Parkinson Disease Foundation, National Parkinson Society, Ontario Problem Gambling Research Centre.

Figures

Figure 1
Figure 1
A diagram showing the primary excitatory drives of the ventral striatum and its modulation by dopamine. The ventral hippocampal input arising from the hippocampal subiculum is believed to be involved in context dependency. As such, this drive should function to maintain focus on the context of the current task to the exclusion of competing stimuli. In contrast, evidence indicates that one function of the medial prefrontal cortex is to facilitate behavioral flexibility, or the propensity to deviate from a task that is no longer rewarding. The dopamine system exerts differential inputs on these pathways, with increased dopamine input facilitating the hippocampal input via a D1-dependent process, whereas D2 stimulation attenuates prefrontal cortical drive. A model of functioning of this system (Sesack & Grace, 2010) suggests that when a task is rewarding, there is an increase in dopamine input, facilitating the hippocampal drive to maintain focus on the currently-rewarded task while preventing the medial prefrontal cortex from deviating from this task. Lower Left. A diagram showing that the hippocampal drive maintains this dopamine input via disinhibition of the VTA via striatal-ventral pallidal circuits. However, if a behavior fails to produce a reward, there would be an attenuation of dopamine neuron activity (negative reward prediction error, decreasing hippocampal drive and disinhibiting the prefrontal cortex. This would enable the prefrontal cortex to shift focus to a different responses. When a response is encountered that produces reward, the resultant increase in dopamine drive would lock the system into the new state by facilitating focus on the new task by the hippocampus while disabling prefrontal behavioral flexibility. Lower Right. A diagram showing disruption of normal ventral striatal function in the event of overactive dopaminergic drive mediated by dopamine agonists, as proposed to occur during ICDs. These agonists have a high affinity for the D2 family of dopamine receptors which reduce excitatory influences from the prefrontal cortex. Thus, an abnormally high and persistent activation of D2 receptors is proposed to circumvent the normal efficient functioning of this gated system, and the balance of influences by inputs from the prefrontal cortex and hippocampus is disrupted. In such conditions, there would be a continued potentiation of hippocampal focus independent of the rewarding nature of the stimuli, causing the organism to perseverate an impulsive task. Because of the high levels of D2 receptor activation, the prefrontal cortex would not be capable of shifting behaviors toward a more goal-oriented condition, thereby locking the system in this behaviorally ineffective state.

References

    1. Weintraub D, Papey K, Siderowf A. Screening for impulse control symptoms in patients with de novo Parkinson disease. Neurology. 2013;80(2):176–180. - PMC - PubMed
    1. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589–595. - PubMed
    1. Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, et al. Impulse control disorders in Parkinson disease: a multicenter case--control study. Ann Neurol. 2011;69:986–996. - PubMed
    1. Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology. 2010;35:2155–2164. - PMC - PubMed
    1. Djamshidian A, Sanotsky Y, Matviyenko Y, O'Sullivan SS, Sharman S, Selikhova M, et al. Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism. Addiction. 2013;108:771–779. - PMC - PubMed

Publication types

MeSH terms

Substances